# Helix BioPharma Reports Fiscal 2026 Loss of C$0.04 Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/44381
Published: 2026-10-30T07:29:46.000Z
Updated: 2026-10-30T07:29:46.000Z
Section: Business

> The loss narrowed from C$0.09 per share a year earlier. Cash reserves were C$804,000 on July 31, compared with C$65,000 a year earlier.

Helix BioPharma Corp. reported a fiscal 2026 loss of C$0.04 per share for the year ended July 31, 2026, a 55.6% narrowing from the C$0.09 loss per share a year earlier.

The company had C$804,000 in cash reserves on July 31, compared with C$65,000 a year earlier.